Ładuje się......
mTOR Inhibitors for Treatment of Low-Risk Prostate Cancer
Prostate cancer incidence increases with age; along with many other cancers, it could be considered a disease of aging. Prostate cancer screening has led to a significant proportion of men diagnosed with low-grade, low-stage prostate cancer who are now more likely to choose an active surveillance st...
Zapisane w:
| Wydane w: | Med Hypotheses |
|---|---|
| Główni autorzy: | , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
2018
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6902872/ https://ncbi.nlm.nih.gov/pubmed/30077200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mehy.2018.06.004 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|